Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a european randomised, phase III, multi-centric study comparing a diagnostic and therapeutic strategy based on molecular analysis followed by suspected primary cancer tailored specific therapy, to an empiric strategy in patients with carcinoma of unknown primary. The purpose of this trial is to determine whether or not a strategy based on molecular analysis is effective in improving the progression free survival rates of patients with carcinoma of unknown primary (CUP).
Epistemonikos ID: 414e227648b4dbffab2d82987ecd0246bab38ae6
First added on: May 10, 2024